Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin
Completed · Phase 1/Phase 2
Conditions studied: Ovarian Cancer, Testicular Germ Cell Tumor
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of paclitaxel, cisplatin, and ifosfamide in treating patients who have ovarian or testicular germ cell tumors that are refractory to platinum-containing chemotherapy.
Key facts
- Study ID
- NCT00002559
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 43
- Starts
- 1994-01-01
- Expected to finish
- 2003-01-01
- Last updated by the study team
- 2013-07-02
Who can join
Age: 15 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.